DavidAaronSchoenfeldMDPhD

PubMed

• Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma.
  David G Su, Wael Ibrahim, Dijana Djureinovic, Raymond Baumann, Ruth Halaban, James Clune, David A Schoenfeld, Raysa Cabrejo, David L Rimm, Sajid A Khan, Harriet M Klug...> ;Journal for Immunotherapy of Cancer. 2024 Mar 21
• Update on Biomarkers in Renal Cell Carcinoma.
  Saliby, R., Saad, E., Kashima, S., Braun, D., Schoenfeld, D.> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2024 Jan 1
• A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better.
  Dijana Djureinovic, Sarah A Weiss, Irina Krykbaeva, Rihao Qu, Ioannis Vathiotis, Myrto Moutafi, Lin Zhang, Ana L Perdigoto, Wei Wei, Gail Anderson, William Damsky, Mic...> ;Molecular Cancer. 2023 Nov 14
• 1 citations
  Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma.
  David Su, Dijana Djureinovic, David Schoenfeld, Bernadette Marquez-Nostra, Kelly Olino, Lucia Jilaveanu, Harriet Kluger> ;Research Square. 2023 Sep 19
• 2 citations
  Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases.
  David A Schoenfeld, Myrto Moutafi, Sandra Martinez, Dijana Djureinovic, Ross D Merkin, Adebowale Adeniran, David A Braun, Sabina Signoretti, Toni K Choueiri, Fabio Par...> ;Journal for Immunotherapy of Cancer. 2023 Aug 1
• Response to "germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu ...
  Lilach Aizenbud, David A Schoenfeld, Jasmine I Caulfield, Jacqueline E Mann, Matthew R Austin, Ana Luisa Perdigoto, Kevan C Herold, Harriet M Kluger> ;Journal for Immunotherapy of Cancer. 2023 Jun 1
• 4 citations
  Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments antitumor activity in melanoma.
  Thuy T Tran, Jasmine Caulfield, Lin Zhang, David Schoenfeld, Dijana Djureinovic, Veronica L Chiang, Victor Oria, Sarah A Weiss, Kelly Olino, Lucia B Jilaveanu, Harriet...> ;JCI Insight. 2023 Apr 10
• 3 citations
  Outcomes With Combination Pembrolizumab and Axitinib in Second and Further Line Treatment of Metastatic Renal Cell Carcinoma.
  Matthew Austin, Bryden Considine, Shlomit Jessel, David Schoenfeld, Man Yee Merl, Michael Hurwitz, Mario Sznol, Harriet Kluger, Dizman, N.> ;Clinical Genitourinary Cancer. 2023 Apr 1
• 5 citations
  Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma.
  David A Schoenfeld, Royce Zhou, Sakellarios Zairis, William Su, Nicole Steinbach, Deepti Mathur, Ankita Bansal, Bertilia Tavarez, Dan Hasson, Emily Bernstein, Raul Rab...> ;Molecular Cancer Research. 2022 Aug 5
• 8 citations
  Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognosti...
  David A Schoenfeld, Ross D Merkin, Myrto Moutafi, Sandra Martinez, Adebowale Adeniran, Deepika Kumar, Lucia Jilaveanu, Michael Hurwitz, David L Rimm, Harriet M Kluger> ;Frontiers in Oncology. 2022 Jan 1
• 44 citations
  PTEN inhibits PREX2-catalyzed activation of RAC1 to restrain tumor cell invasion.
  Sarah M. Mense, Douglas Barrows, Cindy Hodakoski, Nicole Steinbach, David Schoenfeld, William Su, Benjamin D. Hopkins, Tao Su, Barry Fine, Hanina Hibshoosh, Ramon Parsons> ;Science Signaling. 2015 Mar 31
• Join now to see all